BeiGene Ltd (BGNE)

320.00 -9.73  -2.95% NASDAQ Feb 26, 20:00 USD
View Full Chart
Price Chart
View All BGNE News

News

View All Events

Events

Date Type Description
03/02/2021 18:00 EST Misc BeiGene Ltd Fourth Quarter Earnings Conference Call for 2020
03/02/2021 Earnings BeiGene Ltd Fourth Quarter Earnings Results for 2020
11/05/2020 Earnings BeiGene Ltd Third Quarter Earnings Results for 2020
08/06/2020 Earnings BeiGene Ltd Second Quarter Earnings Results for 2020
06/17/2020 Misc BeiGene Ltd Annual General Meeting for 2019
05/11/2020 Earnings BeiGene Ltd First Quarter Earnings Results for 2020
03/02/2020 Earnings BeiGene Ltd Fourth Quarter Earnings Results for 2019
03/02/2020 Misc BeiGene Ltd Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.beigene.com
  • Investor Relations URL: http://ir.beigene.com/phoenix.zhtml?c=254246&p=irol-IRHome
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Large Cap/Growth
  • Next Earnings Release: Mar. 02, 2021
  • Last Earnings Release: Nov. 05, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: BeiGene Ltd is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company has developed a proprietary cancer biology platform that addresses the importance of tumor-immune system interactions and the value of primary biopsies in developing new models to support its drug discovery effort. It has developed clinical-stage drug candidates that inhibit the important oncology targets Bruton's tyrosine kinase, or BTK; RAF dimer protein complex and PARP family of proteins, and an immuno-oncology agent that inhibits the immune checkpoint protein receptor PD-1.

Top Fund Holders

Symbol Name Weighting
CHIH Global X MSCI China Health Care ETF 6.81%
CNCR Loncar Cancer Immunotherapy ETF 4.99%
KURE KraneShares MSCI All China Hlth Care ETF 3.99%
MPACX Matthews Asia Growth Investor 3.93%
REFGX Capital Group Emerging Markets Gr R-6 3.70%
CCWSX Chautauqua International Growth Investor 2.93%
CDWFX American Funds Dvlpg Wld Gr&Inc 529F1 2.44%
BBH VanEck Vectors Biotech ETF 1.97%
POGRX PRIMECAP Odyssey Growth 1.73%
POAGX PRIMECAP Odyssey Aggressive Growth 1.54%
ZCH.TO BMO China Equity ETF 1.28%
IBB iShares Nasdaq Biotechnology ETF 1.26%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.